AbbVie (ABBV) ebitda was $17.6B in FY2025 (+15% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$17.6B
+15%
2024
$15.3B
-17%
2023
$18.5B
-9%
2022
$20.3B
+4%
2021
$19.5B
+52%
2020
$12.8B
-14%
2019
$14.9B
+21%
2018
$12.3B
+18%
2017
$10.4B
+2%
2016
$10.2B
+22%
2015
$8.4B
+106%
2014
$4.1B
-36%
2013
$6.3B
-3%
2012
$6.5B
+51%
2011
$4.3B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$6.8B
Q1 2026
$4.6B
Q4 2025
$4.9B
Q3 2025
$2.3B
Q2 2025
$5.3B
Q1 2025
$4.3B
Q4 2024
$3.4B
Q3 2024
$4.2B
Q2 2024
$4.4B
Q1 2024
$3.3B
Q4 2023
$4.9B
Q3 2023
$4.7B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.